2023
DOI: 10.1007/s10067-023-06744-z
|View full text |Cite
|
Sign up to set email alerts
|

Antibodies against oxidized LDL and atherosclerosis in rheumatoid arthritis patients treated with biological agents: a prospective controlled study

G. V. Papamichail,
A. N. Georgiadis,
C. C. Tellis
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…Among antibodies implicated in the pathogenesis of atherosclerosis in RA, anti-ox-LDL antibodies [ 98 ], which cross-react with antiphospholipids and the anti-ox-LDL/β2GPI complex, are all increased both in SLE and RA [ 99 ]. This evidence offered a first explanation for the increased cardiovascular risk in autoimmunity [ 100 ].…”
Section: Rheumatoid Arthritismentioning
confidence: 99%
“…Among antibodies implicated in the pathogenesis of atherosclerosis in RA, anti-ox-LDL antibodies [ 98 ], which cross-react with antiphospholipids and the anti-ox-LDL/β2GPI complex, are all increased both in SLE and RA [ 99 ]. This evidence offered a first explanation for the increased cardiovascular risk in autoimmunity [ 100 ].…”
Section: Rheumatoid Arthritismentioning
confidence: 99%